GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinew Pharma Inc (ROCO:6634) » Definitions » 5-Year EBITDA Growth Rate

Sinew Pharma (ROCO:6634) 5-Year EBITDA Growth Rate : -7.90% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sinew Pharma 5-Year EBITDA Growth Rate?

Sinew Pharma's EBITDA per Share for the six months ended in Dec. 2024 was NT$-0.86.

During the past 3 years, the average EBITDA Per Share Growth Rate was -13.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sinew Pharma was 12.70% per year. The lowest was -19.70% per year. And the median was 1.80% per year.


Competitive Comparison of Sinew Pharma's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, Sinew Pharma's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinew Pharma's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinew Pharma's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sinew Pharma's 5-Year EBITDA Growth Rate falls into.


;
;

Sinew Pharma 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Sinew Pharma  (ROCO:6634) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Sinew Pharma 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sinew Pharma's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinew Pharma Business Description

Traded in Other Exchanges
N/A
Address
C516, Building C, Number 99, Lane 130, Section 1, Xueyin Road, Nangang District, Taipei, TWN, 11571
Sinew Pharma Inc is a Taiwan-based biopharmaceutical company. The company is mainly engaged in the research and development of new drugs for the treatment of liver diseases and pain relief. Its drug candidates includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.

Sinew Pharma Headlines

No Headlines